610-519-4226
- Brett Regan - ORP Director
For general inquiries, contact the
Institutional Biosafety Committee
The Institutional Biosafety Committee (IBC) oversees all research involving biological materials including some molecules, bacteria, viruses, arthropods and recombinant DNA technology in accordance with guidance from the National Institutes of Health (NIH). In addition, if you are creating transgenic lines of organisms as research models, they could require approval from IBC.
To report compliance issues, call EthicsPoint Hotline toll free 1-955-236-1443.
Deadlines for Full Committee Review Submission
The need for Full Committee Review depends on the type of IBC research being conducted and the exemption status according to the NIH Guidelines. Please refer to the DMR-FCR Guidelines or contact the IBC office for more details.
| Month | Deadline | Meeting Date |
| January 2026 | 1/5/2026 | 1/21/2026 |
| February 2026 | 2/2/2026 | 2/18/2026 |
| March 2026 | 3/2/2026 | 3/18/2026 |
| April 2026 | 3/30/2026 | 4/15/2026 |
| May 2026 | 5/11/2026 | 5/27/2026 |
| *June 2026 | *6/1/2026 | *6/17/2026 |
| *July 2026 | *6/29/2026 | *7/15/2026 |
| *August 2026 | *8/3/2026 | *8/19/2026 |
| September 2026 | TBD | TBD |
| October 2026 | TBD | TBD |
| November 2026 | TBD | TBD |
| December 2026 | TBD | TBD |
*Tentative Meeting Dates